• BMS collaborates with insitro to develop drugs for ALS pharmatimes
    October 30, 2020
    Bristol Myers Squibb has signed a five-year collaboration agreement with machine learning specialist insitro to develop drugs for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
PharmaSources Customer Service